key: cord-1009653-5wz9m4t0
authors: Subramanian, R.; He, Q.; Pascual, M.
title: Quantifying Asymptomatic Infection and Transmission of COVID-19 in New York City using Observed Cases, Serology and Testing Capacity
date: 2020-10-20
journal: nan
DOI: 10.1101/2020.10.16.20214049
sha: 74c0a0a58c1f2d82d2d0d47aed9824462740f8f8
doc_id: 1009653
cord_uid: 5wz9m4t0

The contributions of asymptomatic infections to herd immunity and community transmission are key to the resurgence and control of COVID-19, but are difficult to estimate using current models that ignore changes in testing capacity. Using a model that incorporates daily testing information fit to the case and serology data from New York City, we show that the proportion of symptomatic cases is low, ranging from 13% to 18%, and that the reproductive number may be larger than often assumed. Asymptomatic infections contribute substantially to herd immunity, and to community transmission together with pre-symptomatic ones. If asymptomatic infections transmit at similar rates than symptomatic ones, the overall reproductive number across all classes is larger than often assumed, with estimates ranging from 3.2 to 4.4. If they transmit poorly, then symptomatic cases have a larger reproductive number ranging from 3.9 to 8.1. Even in this regime, pre-symptomatic and asymptomatic cases together comprise at least 50% of the force of infection at the outbreak peak. We find no regimes in which all infection sub-populations have reproductive numbers lower than 3. These findings elucidate the uncertainty that current case and serology data cannot resolve, despite consideration of different model structures. They also emphasize how temporal data on testing can reduce and better define this uncertainty, as we move forward through longer surveillance and second epidemic waves. Complementary information is required to determine the transmissibility of asymptomatic cases, which we discuss. Regardless, current assumptions about the basic reproductive number of SARS-Cov-2 should be reconsidered.

in the absence of immunity, and is estimated on the basis 23 of a particular epidemiological model. Mathematical models 24 for the population dynamics of COVID-19 incorporate dif-25 ferent features such as asymptomatic and pre-symptomatic 26 transmission, super-spreading, or heterogeneity in susceptibil-27 ity. A considerable range of R0 estimates has been reported, 28 ranging from at least 1.5(4) to 5.7(5) in Wuhan. A much 29 narrower range between 2 and 3 is frequently cited in the 30 popular press, or assumed when simulating models(6)or fitting 31 these to data (7, 8) . This assumption may be based on the 32 dynamics of COVID-19 in regions that implemented inter-33 ventions early(9-13). A more precise estimate of R0 from a 34 city where substantial transmission was occurring prior to 35 intervention, such as New York City, would provide a relevant 36 baseline. Furthermore, if "super-spreading" by a small frac-37 tion of symptomatic infections fuels COVID-19 transmission, 38 a precise estimate of the mean number of secondary cases 39 arising from such an individual, may be just as valuable. A 40 model that precisely estimates the fraction of symptomatic 41 cases may help epidemiologists discern if either the overall or 42 symptomatic reproductive numbers are higher than assumed. 43 The probability that a COVID-19 infection is symptomatic 44 is difficult to estimate(14) and a wide range of values have been 45

As health officials face another wave of COVID-19, they require estimates of the proportion of infected cases that develop symptoms, and the extent to which symptomatic and asymptomatic cases contribute to community transmission. Recent asymptomatic testing guidelines are ambiguous. Using an epidemiological model that includes testing capacity, we show that most infections are asymptomatic but contribute substantially to community transmission in the aggregate. Their individual transmissibility remains uncertain. If they transmit as well as symptomatic infections, the epidemic may spread at faster rates than current models often assume. If they do not, then each symptomatic case generates on average a higher number of secondary infections than typically assumed. Regardless, controlling transmission requires community-wide interventions informed by extensive, well-documented asymptomatic testing.

suggested (14-16). Estimates from cruise ship outbreaks(17), tact tracing of index cases(15) may not be representative of

We present a stochastic epidemiological model ( Fig. 1 ) that ex-105 plicitly incorporates daily changes in testing capacity and the 106 lag between sampling and testing (see Methods). The under-107 lying model, referred to hereafter as the SEPIAR model (Fig. 108  1A) has a susceptible-exposed-infectious-recovered structure 109 with compartments for both severe (hospitalized) and non-110 severe symptomatic infections as well as pre-symptomatic (P) 111 and asymptomatic (A) infections. We also consider two nested 112 simplified versions: one with no pre-symptomatic transmission 113 (the SEIAR model, Fig. 1B ); and one with no asymptomatic 114 transmission (the SEPIR model, Fig. 1C ). By varying specific 115 parameters weighting the transmission rate of P and A rela-116 tive to that of symptomatic individuals, we can continuously 117 move across these two extreme structures. 

To evaluate the strength of transmission in asymptomatic 136 cases relative to symptomatic cases, we construct a Monte 137 Carlo profile using the full SEPIAR model (SI Appendix, Fig. 138 S6). We isolate parameter combinations from the profile that 139 are supported by the case and serology data, and examine 140 the values of those combinations. Particular parameters of 141 interest that we focus on include the proportion of cases that 142 are symptomatic, pS, the ratio of the transmission rate of 143 asymptomatic individuals to that of symptomatic individuals, 144 ba , and the reproductive numbers. We use R0 to denote the 145 symptomatic reproductive number (i.e. the mean number of 146 secondary cases arising from each primary symptomatic case), 147 and R0 NGM to denote the overall reproductive number for the 148 model (i.e. the mean number of cases arising from a primary 149 infection, where the average considers all types of infections). 150 The proportion of COVID-19 cases that are symptomatic is 151 well identified, with a confidence interval ranging from 12.9% 152 to 17.4% (Figure 2) . Although a wide range of parameter 153 combinations for the proportion of symptomatic infection are 154 supported by the case data on its own, a much narrower 155 estimate is obtained when the case and serology data are 156 considered together ( Fig. 2A, B) . Within this range, estimates 157 of herd immunity are consistent with the dynamics of observed 158 serology (Fig. 2C) , in particular the rapid rise in seroprevalence 159 over March and April 2020.

The overall reproductive number or symptomatic reproduc-161 tive number may be larger than is often assumed. From our 162 profile of the relative asymptomatic transmission rate ba, we 163 identify two main regimes of transmission that are supported 164 assume that φ U = φ E , when bp = 0 the infectious pre-symptomatic compartment behaves like an additional exposed compartment. C) When the strength of asymptomatic transmission ba is set to 0, the SEPIAR model reduces to the SEPIR model. Individuals in the asymptomatic infectious compartment (A) make no contribution to the force of infection, so asymptomatic individuals essentially recover after leaving the pre-symptomatic period (P ). In all three panels, circular/elliptical compartments contribute to the force of infection, while rectangular compartments do not. The green ellipse denotes the point at which severe/hospitalized COVID patients are sampled and enter the testing queue for severe cases, while the red ellipse denotes the corresponding entry point for the queue for non-severe symptomatic cases. The grey shaded region denotes the 2.5-97.5% quantiles for these simulations from all parameter combinations within 2-log-likelihood units of the MLE with respect to serology (all parameter combinations above the blue line in panel B). The blue line denotes estimates of herd immunity from a recent serological survey in New York City(24). The blue shading denotes 95% confidence intervals for those serology estimates using the methods of (24).

by both the case and serology data ( Fig. 3) , in which either 165 R0 orR0 NGM is higher than the 2-3 range often assumed for 166 COVID-19. Notably, we find no parameter combinations in 167 which both reproductive numbers are below 3 and fall within 168 this range.

In the first regime, asymptomatic individuals transmit at 170 almost the same rate as symptomatic individuals. That is, ba 171 is large, even close to 1 in some parameter combinations. The 172 overall reproductive number takes on values between 3.2 and 173 4.4, and asymptomatic cases substantially contribute to the 174 overall force of infection (Fig. 4) .

In the second regime, asymptomatic individuals transmit 176 at very low rates relative to symptomatic individuals, with 177 estimates of ba close to zero or in some parameter combina-178 tions even equal to zero. Concomitantly, the symptomatic 179 reproductive number is much higher than frequently assumed, 180 taking on values between 3.9 and 8.1. Nevertheless, even in 181 this regime pre-sympomatic and asymptomatic infections to-182 gether contribute at least 50% of the overall force of infection 183 at the peak of the outbreak.

In both regimes, pre-symptomatic individuals transmit at 185 almost the same rate as symptomatic individuals, with esti-186 mates of bp close to 1, also making a substantial contribution 187 to the overall force of infection (Fig. 4) . 188 We also observe a third regime in which both reproductive 189 numbers are higher than assumed, but in this regime pre-190 symptomatic individuals transmit at a very low rate, with bp 191 close to 0. Several combinations in this regime can be observed 192 in the top right corner of Fig. 3 (C,D) and in Fig. S8 . This 193 is also the regime obtained in Fig. S7 if one uses the SEIAR 194 model, which assumes that pre-symptomatic individuals do 195 not transmit (i.e. bp is fixed at 0). Given previous evidence 196 of pre-symptomatic transmission of COVID-19(25, 26), we 197 focus on the two regimes which incorporate substantial pre-198 symptomatic transmission.

In line with previous studies(27), we estimate a large value 200 for the initial number of infected and incubating individuals 201 with COVID-19 in New York City at the start of the simulation 202 on March 1st. Parameter combinations that were supported 203 by the case and serology data ranged from 9,000-18,000 initial 204 infected individuals and 44,000-72,000 exposed individuals. A 205 key question to consider when evaluating the plausibility of 206

In c re a s in

In c re a s in Figure 3 ), we simulate 100 trajectories and calculate the proportion of the overall force of infection on April 14,2020 that is due to asymptomatic, symptomatic, and pre-symptomatic infections. We pool trajectories from all parameter combinations that have the same value of ba, and calculate the median, 2.5%, and 97.5% quantiles for each infection class and value of ba. The colored bars represent for each infection class, the median proportion of its contribution to the force of infection (and hence may not sum exactly to 1). The error bars represent the corresponding 2.5%, and 97.5% quantiles. Versions of this plot calculated respectively 4 weeks before, and 4 weeks after, the peak can be found in the SI Appendix Fig. S10 . We excluded two outlier parameter combinations that had extremely low relative rates of pre-symptomatic transmission (i.e. where bp was less than 0.02). They also contribute substantially to building herd immunity. 237 We use testing information to estimate the probability 238 that a new case will become symptomatic without the bi- If asymptomatic individuals transmit at a high rate, then 267 the overall reproductive number pre-intervention in New York 268 City is larger than the 2-3 range often assumed in models(6-8) 269 and media reports (11, 37-39) based on early estimates from 270 Wuhan (4, 40, 41). Furthermore, we find no supported param-271 eter combinations in which both the overall and symptomatic 272 reproductive numbers fall within this range. Early Wuhan 273 models may under-estimate R0 by ignoring pre-symptomatic 274 transmission and making restrictive assumptions, including 275 that COVID-19 has the same incubation period and serial 276 interval as SARS-CoV (4, 40, 41), or that most cases are 277 symptomatic(42). Early Wuhan case data may be insufficient 278 to precisely estimate R0 without making these assumptions 279 (43-45). Thus, models and intervention strategies should con-280 sider that the overall R0 may be higher than 3 in certain 281 locations (5, 46).

If asymptomatic individuals are unlikely to transmit and 283 do so with low probability, then the small fraction of cases 284 that are symptomatic are transmitting at a high rate, in 285 line with recently reported "super-spreading" events(47, 48). 286 Super-spreading events are instances in which a single infected 287 individual infects a large number of people. These events 288 can be hard to measure on a population level in the absence 289 of detailed transmission data. In classic super-spreading dy-290 namics, most primary cases do not result in many secondary 291 cases, while a subset of primary cases result in a large num-292 ber of secondary cases (8, 49, 50) . This heterogeneity in the 293 reproductive number is indeed what we observe when asymp-294 tomatic individuals transmit poorly. Our model is admittedly 295 a coarse description of this heterogeneity, since it incorpo-296 rates only two different classes of infections, symptomatic or 297 asymptomatic. Future models can build upon this framework 298 with additional classes for age, socio-economic status, location 299 or susceptibility(51) using fine-scale case data. However, our 300 results also indicate that even when the symptomatic repro-301 ductive number is large, pre-symptomatic and asymptomatic 302 infections contribute together to at least 50% of the overall 303 force of infection.

It follows that community-wide interventions that account 305 for non-symptomatic cases should be crucial for mitigating 306 outbreaks. If asymptomatic cases transmit poorly, then concur-307 rent additional interventions targeting super-spreading symp-308 tomatic infections may help reduce community transmission. 309

Resolving the non-identifiability of the efficacy of asymp-310 tomatic transmission (ba), would require extensive community 311 testing and contact tracing of asymptomatic cases. Commu-312 nity testing on its own can provide an estimate of the total 313 proportion of cases that are asymptomatic, but it may not 314 provide insight on whether those asymptomatic individuals 315 can transmit and how well they can transmit. Symptomatic 316 and asymptomatic individuals have similar viral loads(52), but 317 a high viral load does not necessarily imply high transmissi-318 bility. One limitation of early contact tracing studies is that 319 estimates of transmissibility may over-sample symptomatic 320 index cases and contacts, particularly during the early phase 321 of an epidemic(15, 53). In certain studies, only symptomatic 322 contacts are further investigated. Ideally, one would use fre-323 quent systematic community testing for studies identifying 324 both symptomatic and asymptomatic potential index cases 325 for further contact tracing and testing of all contacts regard-326 less of symptoms. Furthermore, fixing the probability that an 327 Our finding that many individuals were already infected by 389 March 1st is consistent with earlier estimates that community 390 transmission began in February in NYC (27, 55, 58) . Previous 391 studies could not explain however why no substantial increase 392 in COVID-19-like illness was observed prior to February 28th 393 in syndrome surveillance data(55). Our simulations show that 394 the lag between infection onset and hospitalization can explain 395 this discrepancy. Even when initialized with many infected 396 cases on March 1st , simulated hospitalizations do not rise 397 until several weeks later concurrent with observed COVID-398 19 hospitalizations (SI Appendix Fig. S5 ). Most likely, the 399 estimated initial conditions suggest multiple parallel foci of 400 initiation of the epidemic with multiple importations of infec-401 tions. Another suggested possibility is a dosage-dependence 402 effect, wherein the severity of an individual's infection depends 403 on the size of the virus population that the person becomes 404 infected with during one or more transmission events, and 405 hence on the overall viral load of COVID-19 in the community. 406 In this scenario, early COVID-19 cases in February and early 407 March would be less severe. This would be consistent with the 408 syndrome surveillance data, where we see a rise in early March 409 of respiratory infection reports in the emergency departments 410 of hospitals, but do not yet see a rise in COVID-19 hospital-411 izations. This phenomenon might also explain why our model 412 slightly under-estimates the peak in daily hospitalizations, 413 even though it correctly identifies the time and shape of that 414 peak.

In conclusion, explicit consideration of changes in testing ca-416 pacity allows us to infer with certainty from case and serology 417 data that most new COVID-19 cases do not become symp-418 tomatic. We also inferred that the overall or symptomatic 419 reproductive number may be larger than often assumed de-420 pending on how well asymptomatic cases can transmit. Despite 421 this uncertainty, the strong consistent contribution to com-422 munity transmission from cases without symptoms observed 423 across scenarios supported by the data, should be considered 424 when formulating public health intervention strategies. Mak-425 ing available detailed information on testing policy and data 426 on testing capacity over time will strengthen the ability of 427 epidemiological models to learn from the past and inform us 428 about the future.

We examine three different model structures that have been used 431 to characterize COVID-19 dynamics in previous studies (Fig 1) . All 

In all models, a fraction p S of exposed individuals Em becomes Overview of the model fitting and inference strategy. 530 Unless otherwise mentioned, we fit the following parameters: the 531 recovery rate for non-severe symptomatic infections (γ), the scaling 532 factors for asymptomatic, pre-symptomatic, and post-intervention 533 transmission (ba, bp, and bq), the symptomatic probability (p S ) 534 and the hospitalization probability (p H ), the reproductive number 535 for symptomatic cases (R 0 ), the dispersion parameter for RT-PCR 536 testing (σ M ), and the initial number of infected (I 0 ) and exposed 537 (E 0 ) individuals at the start of the simulation on March 1, 2020. We 538 use the iterated filtering algorithm MIF(73) within the R-package 539 POMP (for partially observed Markov process models) to fit param-540 eter combinations by likelihood maximization. We apply the Se-541 quential Monte Carlo algorithm pfilter (74) the MLE, we then calculate the likelihood with respect to serology 547 using seroprevalence data from (24). We assume that each serology 548 measurement is drawn from a binomial distribution with sample 549 size N and proportion p equal to the observed seroprevalence. We For each combination, we examine the proportion of cases that 553 are symptomatic p S , the reproductive number in symptomatic 554 individuals R 0 , and the overall reproductive number for the model 555 R 0 NGM . We derive the following expression for R 0 NGM using the 556 Next Generation Matrix(76) : 

Coronavirus infections-more than just the common cold

An interactive web-based dashboard to track covid-19 in real time

Overview of testing for sars

Early transmissibility assessment of a novel coronavirus in wuhan

High contagiousness and rapid spread of severe acute respiratory syndrome 579 coronavirus 2

The implications of silent transmission for the control of covid-19 out-581 breaks

Fundamental principles of epidemic spread highlight the immediate need 583 for large-scale serological surveys to assess the stage of the sars-cov-2 epidemic

Wrong person, place and 585 time: viral load and contact network structure predict sars-cov-2 transmission and super-586 spreading events

Substantial undocumented infection facilitates the rapid dissemination of novel 588 coronavirus (sars-cov-2)

Evolving epidemiology and transmission dynamics of coronavirus disease 590 2019 outside hubei province, china: a descriptive and modelling study. The Lancet Infect

The reproductive number of covid-19 is higher 593 compared to sars coronavirus

Probability of symptoms and critical disease after sars-cov-2 infection

Estimating the extent of asymptomatic covid-19 and its potential for 602 community transmission: systematic review and meta-analysis

Estimating the asymptomatic proportion 604 of coronavirus disease 2019 (covid-19) cases on board the diamond princess cruise ship, 605 yokohama, japan

Estimation of the asymptomatic ratio of novel coronavirus infections

High proportion of asymptomatic sars-cov-2 infections in 9 long-term 610 care facilities

Effect of large-scale testing platform in prevention and control of the covid-19 612 pandemic: an empirical study with a novel numerical model

Estimating effects of intervention measures on covid-614 19 outbreak in wuhan taking account of improving diagnostic capabilities using a modelling 615 approach

New York State Department of Health

Seroconversion of a city: Longitudinal monitoring of sars-cov-2 sero-619 prevalence in new york city

Serial interval of novel coronavirus (covid-19) 621 infections

Spread and dynamics of the covid-19 epidemic in italy: Effects of emergency 623 containment measures

Estimating the establishment of local transmission and the cryptic phase of 625 the covid-19 pandemic in the usa

The rate of underascertainment of novel coronavirus (2019-ncov) infection: 627 Estimation using japanese passengers data on evacuation flights

Three japanese evacuees from wuhan test positive for virus

Impact of non-pharmaceutical interventions (npis) to reduce 632 covid19 mortality and healthcare demand

Critical care utilization for the covid-19 outbreak in lom-634 bardy, italy: Early experience and forecast during an emergency response

Understanding pathways to death in patients with covid-19. The 637 Lancet Respir

Hospitalization and mortality among black 639 patients and white patients with covid-19

Presenting characteristics, comorbidities, and outcomes among 5700 641 patients hospitalized with covid-19 in the new york city area

Practical considerations for measuring the effective reproductive number

The impact of asymptomatic covid-19 infections on future pandemic waves

A guide to r -the pandemic's misunderstood metric

The deceptively simple number sparking coronavirus fears

What is r-naught for the covid-19 virus and why it's a key metric for re-opening 649 plans

Novel coronavirus 2019-ncov: early 652 estimation of epidemiological parameters and epidemic predictions

Estimating clinical severity of covid-19 from the transmission dynamics in 654 wuhan, china

Association of public health interventions with the epidemiology of the covid-19 656 outbreak in wuhan, china

Early dynamics of transmission and control of covid-19: a mathematical 658 modelling study

Pattern of early human-to-human transmission of wuhan 2019 novel 660 coronavirus (2019-ncov)

sur les maladies transmissibles = Eur. communicable disease bulletin

Estimating the effects of non-pharmaceutical interventions on covid-19 in 663 europe

Evaluating transmission heterogeneity and super-665 spreading event of covid-19 in a metropolis of china

Clustering and superspreading potential of severe acute respiratory syndrome coronavirus 2 668 (sars-cov-2) infections in hong kong

Dimensions of superspreading

Superspreading and the effect of individ-671 ual variation on disease emergence

Individual variation in susceptibility or exposure to sars-cov-2 lowers the 673 herd immunity threshold

Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symp-675 tomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Repub-676 lic of Korea

Contact tracing during coronavirus disease outbreak, south korea

Using influenza surveillance networks to esti-680 mate state-specific prevalence of sars-cov-2 in the united states

Evidence for limited early spread of covid-19 within the united states

Syndromic surveillance for influenza in the emer-685 gency department-a systematic review

Syndromic surveillance during pandemic (h1n1) 2009 outbreak

Coast-to-coast spread of sars-cov-2 during the early epidemic in the united 689 states

Infectious diseases of humans: dynamics and control

The importance of the timing of quarantine measures before symptom onset 693 to prevent covid-19 outbreaks -illustrated by hong kong's intervention model

The incubation period of coronavirus disease 2019 (covid-19) from publicly 695 reported confirmed cases: Estimation and application

City of New York, Office of the Mayor, Statement from mayor de blasio on bars, restaurants, 698 and entertainment venues

City of New York, Office of the Mayor

Governor cuomo signs the 'new york state on pause' 701 executive order

Plug-and-play inference for disease dynamics: measles in large 704 and small populations as a case study

Public Health Service, Priorities for testing patients with suspected covid-19 infection

Centers for Disease Control and Prevention, Discontinuation of isolation for persons with 708

Influenza laboratory-confirmed cases by county: Be-710 ginning 2009-10 season

City of New York, Department of Health, Syndromic surveillance data

In vitro diagnostics euas:individual euas for molecular 713 diagnostic tests for sars

Why it takes so long to get most covid-19 test results

Inference for dynamic and latent variable 716 models via iterated, perturbed bayes maps

Statistical inference for partially observed markov processes 718 via the r package pomp

Monte carlo profile confidence intervals for 720 dynamic systems

The construction of next-generation matrices 722 for compartmental epidemic models